199 related articles for article (PubMed ID: 25229404)
21. Societal costs and health related quality of life in adult atopic dermatitis.
Beretzky Z; Koszorú K; Rencz F; Hajdu K; Borza J; Bodai K; Feifei X; Szegedi A; Sárdy M; Brodszky V
BMC Health Serv Res; 2023 Aug; 23(1):859. PubMed ID: 37580792
[TBL] [Abstract][Full Text] [Related]
22. Cost of illness of medically treated benign prostatic hyperplasia in Hungary.
Rencz F; Kovács Á; Brodszky V; Gulácsi L; Németh Z; Nagy GJ; Nagy J; Buzogány I; Böszörményi-Nagy G; Majoros A; Nyirády P
Int Urol Nephrol; 2015 Aug; 47(8):1241-9. PubMed ID: 26093585
[TBL] [Abstract][Full Text] [Related]
23. Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.
Carod-Artal FJ; Mesquita HM; Ziomkowski S; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Nov; 19(11):943-8. PubMed ID: 23831481
[TBL] [Abstract][Full Text] [Related]
24. Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres.
Balogh O; Brodszky V; Gulácsi L; Herédi E; Herszényi K; Jókai H; Kárpáti S; Baji P; Remenyik É; Szegedi A; Holló P
Eur J Health Econ; 2014 May; 15 Suppl 1():S101-9. PubMed ID: 24832841
[TBL] [Abstract][Full Text] [Related]
25. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
26. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
27. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
28. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
29. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
30. [Cystic fibrosis -- disease burden and health-related quality of life of patients and their caregivers: results of the European BURQOL-RD survey in Hungary].
Péntek M; Kosztolányi G; Melegh B; Halász A; Pogány G; Baji P; Brodszky V; Vártokné Hevér N; Boncz I; Gulácsi L
Orv Hetil; 2014 Oct; 155(42):1673-84. PubMed ID: 25305725
[TBL] [Abstract][Full Text] [Related]
31. Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial.
Zahra M; Durand-Zaleski I; Górecki M; Walleser Autiero S; Barnett G; Schüpbach WMM
Health Qual Life Outcomes; 2020 Mar; 18(1):49. PubMed ID: 32122369
[TBL] [Abstract][Full Text] [Related]
32. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
[TBL] [Abstract][Full Text] [Related]
33. Quality of life outcomes following cervical decompression for coexisting Parkinson's disease and cervical spondylotic myelopathy.
Xiao R; Miller JA; Lubelski D; Alberts JL; Mroz TE; Benzel EC; Krishnaney AA; Machado AG
Spine J; 2016 Nov; 16(11):1358-1366. PubMed ID: 27496286
[TBL] [Abstract][Full Text] [Related]
34. QUALITY OF LIFE OF PATIENTS WITH NON-DIABETIC PERIPHERAL NEUROPATHIC PAIN; RESULTS FROM A CROSS-SECTIONAL SURVEY IN GENERAL PRACTICES IN HUNGARY.
Brodszky V; Péntek M; Komoly S; Bereczki D; Embey-Isztin D; Torzsa P; Gulácsi L
Ideggyogy Sz; 2015 Sep; 68(9-10):325-30. PubMed ID: 26665494
[TBL] [Abstract][Full Text] [Related]
35. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
Clarke CE; Patel S; Ives N; Rick CE; Woolley R; Wheatley K; Walker MF; Zhu S; Kandiyali R; Yao G; Sackley CM
Health Technol Assess; 2016 Aug; 20(63):1-96. PubMed ID: 27580669
[TBL] [Abstract][Full Text] [Related]
36. The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson's Disease.
Ramadhan M; Schrag A;
J Geriatr Psychiatry Neurol; 2023 May; 36(3):225-232. PubMed ID: 36264078
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
38. Cost of Parkinson's disease among Filipino patients seen at a public tertiary hospital in Metro Manila.
Prado M; Jamora RD
J Clin Neurosci; 2020 Apr; 74():41-46. PubMed ID: 31983646
[TBL] [Abstract][Full Text] [Related]
39. [Disease burden of psoriasis associated with psoriatic arthritis in Hungary].
Rencz F; Brodszky V; Péntek M; Balogh O; Remenyik E; Szegedi A; Holló P; Kárpáti S; Jókai H; Herszényi K; Herédi E; Szántó S; Gulácsi L
Orv Hetil; 2014 Nov; 155(48):1913-21. PubMed ID: 25417138
[TBL] [Abstract][Full Text] [Related]
40. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
Cubo E; Martínez Martin P; González M; Frades B;
Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
